Results 131 to 140 of about 14,518 (214)

Protection of Myocardial Function and Coronary Vasculature by Streptokinase

open access: bronze, 1988
Judith K. Mickelson   +3 more
openalex   +1 more source

Initial evidence of safety and clinical effect of recombinant streptokinase suppository in acute hemorrhoidal disease. Open, proof-of-concept, pilot trial

open access: yesBiotecnología Aplicada
A proof-of-concept, pilot clinical trial was carried out in 2 hospitals, to evaluate the safety of recombinant streptokinase (rSK) administered by the rectal route in patients with acute hemorrhoidal disease (AHD). Suppositories containing 200 000 IU rSK
Liván Quintero   +15 more
doaj  

Narrative review and creation of an institutional protocol for the use of fibrinolytics in parapneumonic effusion in children. [PDF]

open access: yesJ Pediatr (Rio J)
Frogeri FG   +5 more
europepmc   +1 more source

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

open access: bronze, 1988
Anupama Rao   +9 more
openalex   +1 more source

Microembolism from aortic aneurysm and ventricular thrombus: a complication of intravenous streptokinase [PDF]

open access: bronze, 1994
John S. Abraham   +4 more
openalex   +1 more source

Prognosis of pulmonary embolism associated with syncope: a prospective cohort with the pulmonary embolism registry of Bogodogo university hospital /Burkina Faso. [PDF]

open access: yesBMC Pulm Med
Seghda TAA   +13 more
europepmc   +1 more source

Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. [PDF]

open access: bronze, 1994
M. J. de Boer   +8 more
openalex   +1 more source

The Use of Fibrinolytic Agents in the Salvage of Free Flaps: A Systematic Review. [PDF]

open access: yesJ Pers Med
Mandal P   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy